PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Aug-2025 FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response FoRx Therapeutics
12-Aug-2025 FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy Tiziana Life Sciences
12-Aug-2025 LIEBHERR LAUNCHES NEW UNDER-BENCH FRIDGE AND FREEZERS FOR LABORATORY AND HEALTHCARE PROVIDERS LIEBHERR
12-Aug-2025 PureTech Announces the Launch of Celea Therapeutics with a Mission to Transform the Treatment of Respiratory Diseases Celea Therapeutics
12-Aug-2025 RNA-Based Therapeutics for Hearing Restoration Market to Reach $430 Million by 2032, Driven by Breakthrough Clinical Trials and Expanding Indications globenewswireonlione
12-Aug-2025 Discover How Aletheia Strengthens Your Hospital's HR ACCESS Newswire
12-Aug-2025 Growth Prospects of Heart Valve Devices Market Expected to Reach USD 41.88 Billion by 2035 MBI
12-Aug-2025 FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response FoRx Therapeutics
12-Aug-2025 Trump’s proposed 200-250% tariff on pharma imports to lead to drug shortages and higher prices, says GlobalData GlobalData
12-Aug-2025 MDaudit Finalizes Acquisition of Streamline Health ACCESS Newswire
12-Aug-2025 AI Maverick Intel Provides Corporate Update ACCESS Newswire
12-Aug-2025 Dr. Peter Talisse Joins Ankle & Foot Centers of America, Serving Peachtree City, Newnan, and Fayetteville ACCESS Newswire
12-Aug-2025 IGC Pharma Highlights Alzheimer's Pipeline with Encouraging Preclinical Data on IGC-M3 and Advancing Phase 2 Cannabinoid-Based IGC-AD1 ACCESS Newswire
12-Aug-2025 Arintra Raises $21M Series A to Expand Beyond Autonomous Medical Coding and Build the Future of Healthcare Revenue Assurance ACCESS Newswire
12-Aug-2025 Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates ACCESS Newswire
12-Aug-2025 InnoSIGN Launches First-in-Class Portal to Identify Disease Drivers from Gene Expression Data ACCESS Newswire
12-Aug-2025 Cambridge Cognition launches Speaker Identification Solution to Safeguard Clinical Trial Integrity Cambridge Cognition
12-Aug-2025 Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron
12-Aug-2025 MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin ACCESS Newswire
12-Aug-2025 Lilly and UK Government announce obesity pathway innovation programme for up to £85 million Lilly